Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spontaneous Urticaria, Chronic”

172 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 172 results

Early research (Phase 1)Study completedNCT05373355
What this trial is testing

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

Who this might be right for
Chronic Spontaneous Urticaria
Hangzhou Highlightll Pharmaceutical Co., Ltd 41
Not applicableAvailableNCT05170724
What this trial is testing

Global Managed Access Program Cohort for Remibrutinib in Adult Patients With Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05030311
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Large-scale testing (Phase 3)Study completedNCT05774639
What this trial is testing

Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Kashiv BioSciences, LLC 600
Large-scale testing (Phase 3)Looking for participantsNCT06868212
What this trial is testing

Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Novartis Pharmaceuticals 400
Testing effectiveness (Phase 2)Looking for participantsNCT07415551
What this trial is testing

Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines

Who this might be right for
Allergic DiseasesChronic Spontaneous Urticaria (CSU)
Yuhan Corporation 150
Large-scale testing (Phase 3)UnknownNCT02873364
What this trial is testing

High Dose Vitamin D Supplementation in Chronic Spontaneous Urticaria

Who this might be right for
Urticaria
Shiraz University of Medical Sciences 80
Large-scale testing (Phase 3)Study completedNCT02329223
What this trial is testing

Study of Efficacy and Safety of Omalizumab in Refractory Chronic Spontaneous Urticaria Patients

Who this might be right for
Chronic Spontaneous Uriticaria
Novartis Pharmaceuticals 218
Large-scale testing (Phase 3)Not Yet RecruitingNCT07486583
What this trial is testing

Autologous Whole Blood Therapy in Chronic Idiopathic Urticaria Patients.

Who this might be right for
Chronic Idiopathic Urticaria
Cairo University 40
Large-scale testing (Phase 3)UnknownNCT02166151
What this trial is testing

Efficacy and Safety of Omalizumab in Chronic Idiopathic Urticaria

Who this might be right for
Chronic Idiopathic Urticaria
Rabin Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT03926611
What this trial is testing

This Was a Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 311
Large-scale testing (Phase 3)Study completedNCT05032157
What this trial is testing

Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 455
Testing effectiveness (Phase 2)Study completedNCT03749135
What this trial is testing

Dupilumab in Chronic Spontaneous Urticaria

Who this might be right for
Chronic Spontaneous UrticariaRecurrent Angioedema
Charite University, Berlin, Germany 72
Testing effectiveness (Phase 2)Study completedNCT02031679
What this trial is testing

Efficacy and Safety of Chemoattractant Receptor-homologous Molecule Expressed on T Helper Type 2 (CRTh2) Antagonist AZD1981 in Chronic Idiopathic Urticaria (CIU) Antihistamines

Who this might be right for
Chronic Idiopathic Urticaria
Johns Hopkins University 38
Testing effectiveness (Phase 2)Study completedNCT04109313
What this trial is testing

An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 229
Testing effectiveness (Phase 2)Active Not RecruitingNCT06931405
What this trial is testing

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Who this might be right for
Chronic Inducible UrticariaChronic Spontaneous Urticaria
Blueprint Medicines Corporation 105
Early research (Phase 1)Not Yet RecruitingNCT07684560
What this trial is testing

Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Who this might be right for
Chronic Spontaneous Urticaria (CSU)Healthy Volunteers
AlphaMol Science Ltd. (Shanghai) 48
Large-scale testing (Phase 3)Active Not RecruitingNCT06042478
What this trial is testing

Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 470
Not applicableEnrolling By InvitationNCT07632040
What this trial is testing

Pseudoallergen-Free and Low-Histamine Diet in Adolescents With Chronic Spontaneous Urticaria

Who this might be right for
Pediatric Chronic Spontaneous Urticaria
Istanbul University 120
Large-scale testing (Phase 3)Study completedNCT03580356
What this trial is testing

A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines.

Who this might be right for
Chronic Spontaneous Urticaria
Novartis Pharmaceuticals 1,078
Next Page